Deerfield Beach, FL -- (SBWIRE) -- 03/13/2017 -- Zion Market Research has published a new report titled "Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis And Forecast, 2015 – 2021" According to the report, the global clinical trial imaging market was valued at approximately USD 731.9 million in 2015 and is expected to reach approximately USD 1,052.9 million by 2021, growing at a CAGR of around 6.30% between 2016 and 2021.

Imaging is the technique of generating visual representations of an object or body. Clinical trial imaging uses imaging technology in clinical trials for viewing the interior parts of body. The images obtained from clinical trial imaging are used for diagnose, examine and reveal human body. Screening imaging clinical trials, diagnostic imaging clinical trials and image-guided interventional clinical trials are the key types include in clinical trial imaging. Clinical trial imaging provides quick, detail, accurate diagnosis.

Request Sample Report: http://bit.ly/2clkb5J

Increasing geriatric population and growing occurrences of chronic diseases, are some of the major factors driving the clinical trials imaging market. Growth in pharmaceutical industry is a major factor that is expected to help the growth of the clinical trial imaging in the years to come. Government support and investments coupled with research and development activities especially in countries such as U.S. and UK is anticipated to boost the market growth in the near future. However, high cost of machinery and its installation is a major restraining factor for the market growth.

The clinical trial imaging market is segmented on the basis of service and software. Service accounted for a large chunk of the global clinical trial imaging market in 2015. Software is another leading segment and it accounted for 35.2% share of total market in 2015. This growth is mainly attributed to high investment in R&D activities coupled with government support.

Do Inquiry before buying: http://bit.ly/2d9YpI4

Based on technology, the global clinical trial imaging market is segmented as echo, PET, MRI, X-Ray, CT, and ultrasound and others. The CT segment dominated the market with over 31.0% share of the total market in 2015. MRI, PET and ultrasound are also accounted for significant share owing to the increasing disabled and aging populations who are commonly diagnosed with different disease and other complications.

Some of the key end-users of the clinical trial imaging market include biotech companies, pharmaceutical, research centers, hospitals and others. Among all end-users, pharmaceutical was the leading segment and it accounted for over 45.0% share of the total revenue generated in 2015. Biotech companies another key outlet of the market and expected to exhibit significant growth within the forecast period. This growth is mainly due to rising development in bio-pharmaceutical industries.

Browse the full "Clinical Trial Imaging (Software And Services) By Technology (Echo, PET, MRI, X Ray, CT, Ultrasound And Other) Market For Biotech Companies, Pharmaceuticals, Research Center, Hospitals, And Other End-Users: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at http://www.marketresearchstore.com/report/clinical-trial-imaging-market-z59874

North America dominated the clinical trial imaging market and accounted for over 44.0% share of the global market in 2015. North America was followed by Europe in terms of revenue. The clinical trial imaging market in Asia Pacific region is expected to exhibit significant growth owing to rising government support and rapid growth in population. Latin America and Middle East & Africa are also expected to experience significant growth of clinical trial imaging market in the years to come.

Some of the key players of the global clinical trial imaging market include Cardiovascular Imaging Technologies, VirtualScopic, Biomedical Systems, BioClinica, Intrinsic Imaging LLC, Prism Clinical Imaging, PAREXEL International Corporation, and ICON among others.

This report segments the global clinical trial imaging market as follows:

Clinical Trials Imaging Market: Product Segment Analysis

Service
Software

Clinical Trials Imaging Market: Technology Segment Analysis

X-ray
CT
MRI
PET
Echo
Ultrasound
Other technologies

Clinical Trials Imaging Market: End user Segment Analysis

Biotech companies
Pharmaceutical
Research centers
Hospitals
Other end users

Clinical trial imaging Market: Regional Segment Analysis

North America
US
Europe
Germany
France
UK
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa

Similar Reports :-

Browse the full "Healthcare Information System by Delivery Sources (On-Premise Technology, Cloud Based Technology, Web Based Technology) Market for Pharmacy Information System, Hospital Information System and Laboratory Information System Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast 2014 – 2020" report at http://www.marketresearchstore.com/report/healthcare-information-system-market-z51360

Browse the full "Clinical Diagnosis Automation (Modular and Total Lab) Market for Clinical Diagnostics, Drug Discovery, Proteomics Solutions and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 – 2020" report at http://www.marketresearchstore.com/report/clinical-diagnosis-automation-market-z53040

Browse the full "Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance Spectroscopy), Indication (Cardiology and Oncology) for Drug Discovery, Biomarker and Nutrigenomics: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021" report at http://www.marketresearchstore.com/report/metabolomics-market-z55501

Contact US:
Joel John
3422 SW 15 Street, Suite #8138
Deerfield Beach, Florida 33442
United States
Toll Free: 855-465-4651 (USA-CANADA)
Tel: 386-310-3803
Email: sales@marketresearchstore.com
Website: http://www.marketresearchstore.com